LifeScan

LifeScan today announced positive data from a study of real-world evidence supporting its Bluetooth-connected blood glucose meter.

Evidence from more than 55,000 people with diabetes demonstrated sustained improvements in readings in range. The analysis focuses on changes over 180 days. LifeScan published results in the peer-reviewed journal Diabetes Therapy.

The company’s OneTouch Bluetooth-connected blood glucose meter and mobile diabetes app provides simplicity, accuracy and trust, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

LifeScan announced today that it launched its OneTouch solutions offering wellness programs to help people manage their diabetes.

Malvern, Pennsylvania-based LifeScan made its OneTouch solutions available to consumers in the U.S. now and plans to soon offer it to healthcare providers, payors and employers as a reimbursed adjudicated option in early 2022.

Get the full story at our sister site, Drug Delivery Business News.